Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 2.73TCr 3.16TCr 403.03Cr 345.28Cr 315.7Cr 298.96Cr 553.49Cr 39TCr 557.96Cr 3.77TCr 1.46TCr 18TCr 1.51TCr 1.48TCr 64TCr P/E ratio 2026 *
14.2x
P/E ratio 2027 * 12.4x
Enterprise value 1.98TCr 2.29TCr 292.23Cr 250.35Cr 228.91Cr 216.77Cr 401.33Cr 28TCr 404.56Cr 2.73TCr 1.06TCr 13TCr 1.1TCr 1.07TCr 46TCr EV / Sales 2026 *
3.22x
EV / Sales 2027 * 2.71x
Free-Float
43.65%
Yield 2026 *
4.44%
Yield 2027 * 4.42%
1 day-3.76%
1 week-0.54%
Current month-1.66%
1 month+7.07%
3 months-11.29%
6 months-24.54%
Current year-10.76%
1 week 29.68
Extreme 29.68
31.94
1 month 28.22
Extreme 28.22
33.36
Current year 27.2
Extreme 27.2
38
1 year 27.2
Extreme 27.2
87.1
3 years 27.2
Extreme 27.2
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
Manager TitleAgeSince
Chief Executive Officer 59 21/04/2022
Director of Finance/CFO 39 21/04/2022
Corporate Secretary 30 01/10/2018
Director TitleAgeSince
Chairman 59 21/04/2022
Director/Board Member 55 30/11/2021
Director/Board Member 67 06/10/2022
Change 5d. change 1-year change 3-years change Capi.($)
-3.76%-0.54%-63.98%-16.10% 418.41Cr
+1.02%-1.73%-9.16%-7.99% 33TCr
-0.27%-2.01%-17.69%-13.38% 12TCr
+1.74%+2.16%+1.92%+10.08% 7.03TCr
-0.82%-2.95%-4.72%-14.28% 6.12TCr
+0.26%-2.88%-25.82%-37.42% 3.3TCr
-0.82%-4.33%+27.28%-59.44% 2.97TCr
-0.48%-1.32%-9.46%-18.78% 1.83TCr
+1.00%-3.02%-40.54%-44.34% 1.79TCr
+0.27%-5.56%-18.40%+3.41% 1.1TCr
Average -0.24%-2.45%-16.06%-19.82% 7.02TCr
Weighted average by Cap. +0.47%-3.11%-9.70%-12.33%

Financials

2026 *2027 *
Net sales 615.42Cr 710.42Cr 91Cr 78Cr 71Cr 67Cr 124.56Cr 8.67TCr 125.57Cr 847.9Cr 329.35Cr 4.12TCr 340.39Cr 333.12Cr 14TCr 700.39Cr 808.5Cr 103.22Cr 88Cr 81Cr 77Cr 141.76Cr 9.87TCr 142.9Cr 964.96Cr 374.82Cr 4.69TCr 387.38Cr 379.11Cr 16TCr
Net income 193.78Cr 223.69Cr 29Cr 24Cr 22Cr 21Cr 39Cr 2.73TCr 40Cr 266.98Cr 103.7Cr 1.3TCr 107.18Cr 104.89Cr 4.52TCr 223.62Cr 258.13Cr 33Cr 28Cr 26Cr 24Cr 45Cr 3.15TCr 46Cr 308.09Cr 119.67Cr 1.5TCr 123.68Cr 121.04Cr 5.21TCr
Net Debt -751.79Cr -867.84Cr -110.8Cr -95Cr -87Cr -82Cr -152.16Cr -11TCr -153.39Cr -1.04TCr -402.33Cr -5.03TCr -415.81Cr -406.94Cr -18TCr -836.56Cr -965.69Cr -123.29Cr -105.63Cr -97Cr -91Cr -169.32Cr -12TCr -170.69Cr -1.15TCr -447.69Cr -5.6TCr -462.7Cr -452.82Cr -19TCr
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
Employees
2,201
Date Price Change Volume
14/26/14 29.70 $ -3.76% 49,04,312
13/26/13 30.86 $ -0.32% 65,69,736
12/26/12 30.96 $ +2.11% 43,27,003
11/26/11 30.32 $ -2.51% 50,77,174
08/26/08 31.10 $ -0.83% 42,98,031
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
29.70HKD
Average target price
44.08HKD
Spread / Average Target
+48.43%

Quarterly revenue - Rate of surprise